REBECCA BOWMAN: Open Payments
NPI 1376966838 · WARREN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,340 in 258 payments from 23 companies in 2025. Trend: 2023 $3,365 · 2024 $4,461 · 2025 $5,340
Food & beverage: $5,245Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 106 | $1,808 |
| GENZYME CORPORATION | 13 | $608 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $567 |
| Phathom Pharmaceuticals, Inc. | 20 | $305 |
| Lilly USA, LLC | 5 | $292 |
| Gilead Sciences, Inc. | 14 | $267 |
| Janssen Biotech, Inc. | 10 | $259 |
| Ipsen Biopharmaceuticals, Inc | 5 | $198 |
| Novo Nordisk Inc | 5 | $187 |
| Aimmune Therapeutics, Inc. | 10 | $166 |
Products named: RINVOQ, DUPIXENT, ENTYVIO, VOQUEZNA, OMVOH, TREMFYA, SKYRIZI, CREON.
Industry payments across OH — which companies pay providers there.
